On 18 November 2020, Immunicum and DCprime combined forces to establish a leading company in cell-based cancer immunotherapies. The full announcement is available below.

Immunicum AB and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies

Prospectus (Swedish): Prospekt med anledning av upptagande till handel av nyemitterade aktier i Immunicum AB (publ)